TANIA MESSMER: Open Payments
NPI 1528000114 · OAKBROOK TERRACE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 44 payments from 13 companies in 2025. Trend: 2023 $17 · 2024 $499 · 2025 $887
Food & beverage: $836Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $161 |
| Janssen Biotech, Inc. | 5 | $142 |
| GENZYME CORPORATION | 3 | $78 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| Biocon Biologics Inc | 2 | $54 |
| Gilead Sciences, Inc. | 2 | $45 |
| Celltrion USA Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, RINVOQ, ZENPEP, SKYRIZI, Yesintek, VEGZELMA.
Industry payments across IL — which companies pay providers there.
